Physician profile
Robert J Vissing
NPI 1457352395
$3,392.48
in general payments reported to CMS, 2019-2025
20 companies · $606 in 2025
The $606 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $15.37 · 2021: $327 · 2022: $364 · 2023: $608 · 2024: $715 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $699.88 | 2019-2024 | |
| Abbvie INC. | $351.98 | 2022-2025 | Ubrelvy, Qulipta, Synthroid |
| Novo Nordisk INC | $326.37 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $264.17 | 2019-2025 | Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $186.83 | 2019-2022 | |
| Glaxosmithkline, LLC. | $157.73 | 2022-2024 | Arexvy, Trelegy Ellipta |
| Astellas Pharma US INC | $154.47 | 2024 | Veozah |
| Exact Sciences Corporation | $139.63 | 2023 | Cologuard Collection Kit |
| Corcept Therapeutics | $124.98 | 2025 | Korlym |
| Abbott Laboratories | $121.82 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.59 | 2025 | |
| Pfizer INC. | $119.90 | 2019 | |
| Horizon Therapeutics Plc | $112.95 | 2023 | Krystexxa |
| Amarin Pharma, INC. | $108.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $106.15 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $101.40 | 2025 | Inspire |
| Lilly USA, LLC | $96.66 | 2025 | Zepbound |
| Nevro Corp. | $61.07 | 2022-2024 | Senza |
| Tms Neurohealth Centers INC. | $20.70 | 2025 | Tms Neurohealth Centers INC. |
| Novartis Pharmaceuticals Corporation | $16.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Vissing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.